This article is more than 5 years old. Information may no longer be current.

Dana-Farber names medical director

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Jeanna Walsh, MD, has been named medical director of Dana-Farber/New Hampshire Oncology-Hematology in Londonberry, N.H.

“I am honored and excited to take over the directorship of Dana-Farber’s Londonderry satellite,” Walsh said in a press release. “The clinic has developed into a key center of oncology care in southern New Hampshire. I hope to continue these traditions of high quality cancer care and work to enhance the excellent programs that support our patients, their families and the broader community.”

Walsh will succeed Frederick M. Briccetti, MD, who led Dana-Farber/ New Hampshire Oncology-Hematology since it opened in 2008. Briccetti will continue to see patients in Londonderry and is expected to be actively involved in the clinical trial program.

“It has been my privilege to serve as medical director,” Briccetti said. “I am proud of how the collaboration between Dana-Farber and NHOH has enhanced the cancer care we are able to provide in southern New Hampshire.”